FBN1 and Marfan syndrome: Genetic loss of TGF-β signaling significantly slowed myxomatous changes, but blockade of monocyte recruitment failed to prevent myxomatous changes conferred either by loss of KLF2/4 or by expression of the mutant FBN1 C1039G protein associated with Marfan syndrome.